We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+20.76%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.9B
AUM Growth
+$2.99B
(+30%)
Cap. Flow
+$1.15B
Cap. Flow
% of AUM
8.87%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
2,001
New
167
Increased
892
Reduced
787
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$188M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$143M |
| 3 |
Apple
AAPL
|
+$66.1M |
| 4 |
Amazon
AMZN
|
+$65.5M |
| 5 |
Microsoft
MSFT
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNO Financial Group
CNO
|
+$19.2M |
| 2 |
Gen Digital
GEN
|
+$11.2M |
| 3 |
Reinsurance Group of America
RGA
|
+$10.7M |
| 4 |
RTN
Raytheon Company
RTN
|
+$10.2M |
| 5 |
AES
AES
|
+$8.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.71% |
| 2 | Healthcare | 10.09% |
| 3 | Financials | 7.77% |
| 4 | Consumer Discretionary | 7.59% |
| 5 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDK
751
DELISTED
CDK Global, Inc.
CDK
| $2.72M | 0.02% |
65,601
+54,206
| +476% | +$2.09M |
|
752
Labcorp
LH
$25.9B
| $2.71M | 0.02% |
19,003
+1,118
| +6% | +$155K |
|
|
PACW
753
DELISTED
PacWest Bancorp
PACW
| $2.71M | 0.02% |
137,512
-7,008
| -5% | -$130K |
|
|
IDE
754
Voya Infrastructure, Industrials and Materials Fund
IDE
$198M
| $2.69M | 0.02% |
297,717
+16,946
| +6% | +$147K |
|
755
Ball Corp
BALL
$16.8B
| $2.68M | 0.02% |
38,588
+123
| +0.3% | +$8.31K |
|
|
PPLT
756
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
| $2.67M | 0.02% |
341,870
-98,630
| -22% | -$738K |
|
757
Moody's
MCO
$82.7B
| $2.67M | 0.02% |
9,712
-2,318
| -19% | -$589K |
|
758
Teledyne Technologies
TDY
$32B
| $2.66M | 0.02% |
8,562
+1,310
| +18% | +$431K |
|
|
JTD
759
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $2.66M | 0.02% |
208,023
+102,083
| +96% | +$1.28M |
|
760
Goldman Sachs BDC
GSBD
$1.1B
| $2.65M | 0.02% |
163,279
+23,989
| +17% | +$370K |
|
761
Paycom
PAYC
$9.69B
| $2.64M | 0.02% |
8,523
-511
| -6% | -$136K |
|
762
Barings BDC
BBDC
$965M
| $2.64M | 0.02% |
332,329
+49,942
| +18% | +$359K |
|
763
iShares Russell 1000 Value ETF
IWD
$83.9B
| $2.64M | 0.02% |
23,424
-5,953
| -20% | -$655K |
|
764
Ligand Pharmaceuticals
LGND
$6.36B
| $2.64M | 0.02% |
37,771
+888
| +2% | +$56.3K |
|
765
PTC Therapeutics
PTCT
$6.12B
| $2.63M | 0.02% |
51,756
+5,421
| +12% | +$266K |
|
766
Ralph Lauren
RL
$23.6B
| $2.6M | 0.02% |
35,782
+2,401
| +7% | +$177K |
|
|
EVF
767
Eaton Vance Senior Income Trust
EVF
$90.5M
| $2.58M | 0.02% |
484,312
-179,234
| -27% | -$919K |
|
768
IAMGOLD
IAG
$10.5B
| $2.58M | 0.02% |
652,475
+53,097
| +9% | +$183K |
|
769
GSK
GSK
$106B
| $2.56M | 0.02% |
50,306
+1,304
| +3% | +$66.9K |
|
770
Universal Health Services
UHS
$10.5B
| $2.55M | 0.02% |
27,497
+11,376
| +71% | +$1.14M |
|
|
ALE
771
DELISTED
Allete
ALE
| $2.55M | 0.02% |
46,718
-9,665
| -17% | -$548K |
|
772
Invesco
IVZ
$13.9B
| $2.54M | 0.02% |
236,416
+10,796
| +5% | +$96.8K |
|
|
BNY
773
DELISTED
BlackRock New York Municipal Income Trust
BNY
| $2.54M | 0.02% |
188,072
-1,430
| -0.8% | -$18.8K |
|
774
Equinox Gold
EQX
$13.5B
| $2.54M | 0.02% |
+226,513
| New | +$2.03M |
|
|
BKI
775
DELISTED
Black Knight, Inc. Common Stock
BKI
| $2.53M | 0.02% |
34,921
+31,268
| +856% | +$2.22M |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
WANY
ACA
ZIG
Guggenheim Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Guggenheim Capital held 2,001 positions worth $12.9B, up 30% from $9.93B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Guggenheim Capital deployed $1.15B of net new capital in Q2 2020, opening 167 new positions and adding to 892 existing holdings. Its largest new stake was SelectQuote: 1,199,960 shares worth $30.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CNO Financial Group, an estimated $19.2M trimmed.
- Guggenheim Capital's largest Q2 2020 buy was SelectQuote: 1,199,960 shares worth $30.4M.
- Guggenheim Capital added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $188M increase.
- Guggenheim Capital's biggest Q2 2020 reduction was CNO Financial Group, cutting an estimated $19.2M.
- Guggenheim Capital fully exited Raytheon Company in Q2 2020, selling an estimated $10.2M.
- Guggenheim Capital's ten largest holdings make up 23% of its $12.9B portfolio in Q2 2020.
- Guggenheim Capital opened 167 new positions and closed 133 in Q2 2020.
- Guggenheim Capital's portfolio value rose 30% quarter-over-quarter to $12.9B.
Based on Guggenheim Capital's 13F filing for Q2 2020, filed 14 Aug 2020.